Cargando…
An overview of Ebola virus disease
Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush me...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175058/ https://www.ncbi.nlm.nih.gov/pubmed/28058346 http://dx.doi.org/10.14744/nci.2015.97269 |
_version_ | 1782484585841426432 |
---|---|
author | Kadanali, Ayten Karagoz, Gul |
author_facet | Kadanali, Ayten Karagoz, Gul |
author_sort | Kadanali, Ayten |
collection | PubMed |
description | Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat. EVD has an incubation period of 2 to 21 days, and the infection has an acute onset without any carrier status. Currently, there is no standard treatment for EVD, so it is important to avoid infection or further spreading of the virus. Although historically the mortality of this infection exceeded 80%, modern medicine and public health measures have been able to lower this figure and reduce the impact of EBOV on individuals and communities. Its treatment involves early, aggressive supportive care with rehydration. Clinicians should consider the possibility of EVD in persons with travel or exposure history with the incubation period presenting constitutional symptoms in order to promptly identify diseased patients, and prevent further spreading of the disease. |
format | Online Article Text |
id | pubmed-5175058 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Kare Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-51750582017-01-05 An overview of Ebola virus disease Kadanali, Ayten Karagoz, Gul North Clin Istanb Review Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat. EVD has an incubation period of 2 to 21 days, and the infection has an acute onset without any carrier status. Currently, there is no standard treatment for EVD, so it is important to avoid infection or further spreading of the virus. Although historically the mortality of this infection exceeded 80%, modern medicine and public health measures have been able to lower this figure and reduce the impact of EBOV on individuals and communities. Its treatment involves early, aggressive supportive care with rehydration. Clinicians should consider the possibility of EVD in persons with travel or exposure history with the incubation period presenting constitutional symptoms in order to promptly identify diseased patients, and prevent further spreading of the disease. Kare Publishing 2015-04-24 /pmc/articles/PMC5175058/ /pubmed/28058346 http://dx.doi.org/10.14744/nci.2015.97269 Text en Copyright: © Istanbul Northern Anatolian Association of Public Hospitals http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Review Kadanali, Ayten Karagoz, Gul An overview of Ebola virus disease |
title | An overview of Ebola virus disease |
title_full | An overview of Ebola virus disease |
title_fullStr | An overview of Ebola virus disease |
title_full_unstemmed | An overview of Ebola virus disease |
title_short | An overview of Ebola virus disease |
title_sort | overview of ebola virus disease |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175058/ https://www.ncbi.nlm.nih.gov/pubmed/28058346 http://dx.doi.org/10.14744/nci.2015.97269 |
work_keys_str_mv | AT kadanaliayten anoverviewofebolavirusdisease AT karagozgul anoverviewofebolavirusdisease AT kadanaliayten overviewofebolavirusdisease AT karagozgul overviewofebolavirusdisease |